Photo of William F Pirl,  MD, MPH

William F Pirl, MD, MPH

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-2691


william_pirl@dfci.harvard.edu

William F Pirl, MD, MPH

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Associate Professor, Psychiatry, Harvard Medical School
  • Vice Chair for Psychosocial Oncology, Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Publications

Powered by Harvard Catalyst
  • Pirl WF, Saez-Flores E, Schlumbrecht M, Nipp R, Traeger LN, Kobetz E. Race and Ethnicity in the Evidence for Integrating Palliative Care Into Oncology. J Oncol Pract 2018; 14:e346-e356. PubMed
  • Pirl WF, Greer JA, Park E, Safren SA, Fields L, Wood L, Traeger L, El-Jawahri A, Zebrack B, Temel JS. Development and evaluation of a six-day training program in supportive oncology research. 2018. PubMed
  • Jacobs JM, Traeger L, Eusebio J, Simon NM, Sequist LV, Greer JA, Temel JS, Pirl WF. Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study. J Psychosom Res 2017; 99:28-33. PubMed
  • Pirl WF, Greer JA, Irwin K, Lennes IT, Jackson VA, Park ER, Fujisawa D, Wright AA, Temel JS. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract 2015. PubMed